NCT01873326 2025-07-03Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell TumorsMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting92 enrolled